Search research articles
Contact Us
Filters
Showing results (61-70 of 285) with videos related to
Page
of 29
Sort By:
Journal of the National Cancer Institute
|
December 28, 2020
Ki67 Assessment in Breast Cancer: Are We There Yet?
Jorge S Reis-Filho, Nancy E Davidson
Molecular Oncology
|
April 14, 2012
Hematopoietic growth factors: personalization of risks and benefits
Shannon Puhalla, Saveri Bhattacharya, Nancy E Davidson
Pharmacogenomics
|
December 26, 2006
Role of CYP2D6 testing in selection of endocrine therapy for breast cancer
Justin Stebbing, Vered Stearns, Nancy E Davidson
Cancer Biology & Therapy
|
December 19, 2006
Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation
Qun Zhou, Peter Atadja, Nancy E Davidson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2006
Epigenetic biomarkers and breast cancer: cause for optimism
Kala Visvanathan, Saraswati Sukumar, Nancy E Davidson
Breast (Edinburgh, Scotland)
|
December 9, 2003
New findings about endocrine therapy for breast cancer
Nancy E Davidson, Kala Visvanathan, Leisha Emens
Molecular Oncology
|
March 13, 2012
Hormonal therapy in breast cancer: a model disease for the personalization of cancer care
Shannon Puhalla, Saveri Bhattacharya, Nancy E Davidson
Journal of the National Cancer Institute
|
May 14, 2009
Small beginnings: do they matter? The importance of lymphovascular invasion in early breast cancer
Mamatha Chivukula, Adam Brufsky, Nancy E Davidson
Cancer Investigation
|
December 7, 2007
Epigenetic regulation as a new target for breast cancer therapy
Vered Stearns, Qun Zhou, Nancy E Davidson
Methods in Molecular Biology (Clifton, N.J.)
|
September 14, 2011
Inhibition of histone deacetylases
Yi Huang, Patrick G Shaw, Nancy E Davidson
Page
of 29
Search research articles
Search
Showing results (61-70 of 285) with videos related to
Sort By:
Page
of 29
Journal of the National Cancer Institute
|
December 28, 2020
Ki67 Assessment in Breast Cancer: Are We There Yet?
Jorge S Reis-Filho, Nancy E Davidson
Molecular Oncology
|
April 14, 2012
Hematopoietic growth factors: personalization of risks and benefits
Shannon Puhalla, Saveri Bhattacharya, Nancy E Davidson
Pharmacogenomics
|
December 26, 2006
Role of CYP2D6 testing in selection of endocrine therapy for breast cancer
Justin Stebbing, Vered Stearns, Nancy E Davidson
Cancer Biology & Therapy
|
December 19, 2006
Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation
Qun Zhou, Peter Atadja, Nancy E Davidson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2006
Epigenetic biomarkers and breast cancer: cause for optimism
Kala Visvanathan, Saraswati Sukumar, Nancy E Davidson
Breast (Edinburgh, Scotland)
|
December 9, 2003
New findings about endocrine therapy for breast cancer
Nancy E Davidson, Kala Visvanathan, Leisha Emens
Molecular Oncology
|
March 13, 2012
Hormonal therapy in breast cancer: a model disease for the personalization of cancer care
Shannon Puhalla, Saveri Bhattacharya, Nancy E Davidson
Journal of the National Cancer Institute
|
May 14, 2009
Small beginnings: do they matter? The importance of lymphovascular invasion in early breast cancer
Mamatha Chivukula, Adam Brufsky, Nancy E Davidson
Cancer Investigation
|
December 7, 2007
Epigenetic regulation as a new target for breast cancer therapy
Vered Stearns, Qun Zhou, Nancy E Davidson
Methods in Molecular Biology (Clifton, N.J.)
|
September 14, 2011
Inhibition of histone deacetylases
Yi Huang, Patrick G Shaw, Nancy E Davidson
Page
of 29